Propelling: Even with Varied Regulations, the Middle East is Transforming Drone Usage, with Charles Al Rachid of Microdrones

 

Drones are revolutionizing the way that many companies do business all over the world, and that’s not limited to just a few countries. Though everyone feels the impact, not every country handles the growth the same. The United States is under FAA regulation and Canada follows Transport Canada rules; what do the laws and regulations look like in countries within the Middle East, and how do they’re projects influence the market in unique ways?

On this episode ofOn this episode of Propelling, we sat down with Charles Al Rachid, Middle East regional sales manager for Microdrones. Our discussion covers regulations and how they’ve changed since 2009. Charles was actually part of the team that worked with different government agencies within the UAE and Saudi Arabia, to help develop some of the original guidelines and regulations in 2009. According to Al Rachid, the goal is always to enable companies “to be able to provide their services in a safe, secure, and legal way.”

We also review how they’ve modernized the certification process. The practice used to involve a complicated inspection process with a lengthy trail of paperwork. Now in 2019, the process is completely online, where all drones can be registered and the pilots are required to pass a license evaluation test. According to Al Rachid, “It’s a very easy, quite straightforward automated online process.”

Complicating drone use in the Middle East are the various rules and regulations governing flights throughout the area. The region hasn’t unified their drone regulation under one framework, meaning from city to city, drone pilots need to be aware of the different rules in effect. Al Rachid points to a need for educating pilots on the ever-changing and diverse set of regulations in the Middle East.

Listen to Al Rachid explain the most interesting use cases for drones in the Middle East, the best ways to get clients to find tangible benefits from implementing drones into their workflow, and some of the best prospects for growth of the drone market in the Middle East.

For the latest news, videos, and podcasts in the Software & Electronics Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @TechMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More